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Objectives. The aim of this study was to characterize fully in
vivo aortic compliance over a wide range of passive distending
pressures, and to study pharmacologically induced alterations in
compliance using an intravascular ultrasound–based technique
in the canine model of heart failure.
Background. Altered aortic compliance may influence consid-
erably the function of the failing heart. Although some studies
demonstrate that patients with heart failure have decreased aortic
compliance, data from other studies are conflicting.
Methods. Aortic pressures and dimensions in seven dogs were
determined both before and after pacing-induced congestive heart
failure (CHF) using simultaneous micromanometer and intravas-
cular ultrasound transducers. Decreases in aortic pressure were
produced at baseline and after nitroprusside and dobutamine
infusions. Inner and outer aortic circumferences were drawn at
the lumen–intimal and media–adventitial borders.
Results. Aortic pressure–dimension (chamber) stiffness con-
stants were greater after heart failure was produced (10.0 6 1.5
vs. 6.7 6 1.5, p < 0.05), but stress–strain stiffness (material)
constants were similar (11.4 6 1.8 vs. 11.3 6 1.0, p 5 NS).
Equivasodilating doses of nitroprusside and 10 mg/kg/min dobut-
amine decreased pressure–dimension stiffness constants after
pacing-induced heart failure but not beforehand. The aortic wall
thickness to diameter ratio was significantly greater in CHF than
in the control condition (0.30 6 0.08 vs. 0.16 6 0.03, p < 0.01).
Conclusions. Aortic compliance is decreased in this model of
CHF, and this change is attributable primarily to vessel geometry
rather than material properties. Equivasodilating doses of nitro-
prusside and equivalent doses of dobutamine increase aortic cham-
ber compliance in dogs with CHF, but not in normal dogs. These data
suggest that the beneficial effects of nitroprusside and dobutamine in
CHF occur in part from improvement in aortic compliance.
(J Am Coll Cardiol 1999;33:267–72)
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The input impedance of the arterial system is an important
determinant of the stroke work and power output of the left
ventricle (1–3) and is comprised of systemic vascular resis-
tance, total arterial compliance and wave reflections (4). A
decrease in aortic compliance (i.e., increase in stiffness) rep-
resents an increase in the opposition to left ventricular ejec-
tion, and therefore is a component of the ventricular afterload
(5); as such, altered aortic compliance may influence consid-
erably the function of the failing heart. Although some studies
demonstrate that patients with heart failure (6,7) have de-
creased aortic compliance, data from other studies are con-
flicting (8,9).
Various models have been used to assess the elastic behav-
ior and compliance of the aorta. In vitro studies employ either
segments, rings or helical strips cut from blood vessels and
measure force–length relations and wall thickness (10). These
methods are limited by the inability to extrapolate to the intact
circulation and because isolated aortic specimens are difficult
to maintain. Early investigations of arterial elasticity in vivo
attached instruments to blood vessels in situ (11); however,
these techniques impose mechanical constraints on the vessel,
and are therefore undesirable. More recently aortic distensi-
bility and pressure–dimension relations of the aorta have been
accomplished with transcutaneous and intravascular ultra-
sound (12–14).
Accordingly, the aim of this study was to characterize fully
in vivo aortic compliance over a wide range of passive distend-
ing pressures, and to study pharmacologically induced alter-
ations in compliance using an intravascular ultrasound
(IVUS)-based technique in the canine model of heart failure
(15). Specifically, we tested the hypothesis that compliance in
the abdominal aorta is decreased in dogs with pacing-induced
heart failure owing to altered aortic geometry and that com-
pliance can be pharmacologically modulated.
Methods
The experimental protocol was approved by the Institu-
tional Animal Care and Use Committee at the University of
Cincinnati.
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Seven adult mongrel conditioned dogs, weighing 22.2 6
3.2 kg, were used for this study. Animals were anesthetized
with pentobarbital (30 mg/kg/IV), intubated and ventilated. A
unipolar pacemaker lead was passed via the right internal
jugular vein into the right ventricular apex, and a pulse
generator (Medtronic Spectrax) was implanted in the subcu-
taneous tissue over the back of the neck. Rapid ventricular
pacing at 250 bpm for 3–4 weeks was used to produce low
output heart failure (15).
Instrumentation. At the time of study, animals were placed
on a fluoroscopy table, anesthetized with pentobarbital (30
mg/kg/IV), intubated and ventilated. A table warmer was used
to ensure normothermia. Under fluoroscopic guidance, a 7-F
Fogarty catheter was advanced into the descending aorta via
the carotid artery to a level just above the 12th rib. An 8-F
triple lumen thermodilution catheter was advanced into the
pulmonary artery via the jugular vein. The femoral arteries
were secured by cutdowns through which a 5-F Millar micro-
manometer and a 6.2-F IVUS catheter with a 12-MHz ultra-
sound transducer (Sonocath CV, Mansfield) were advanced
through a 10-F sheath into the descending aorta to the level of
the 12th rib. The micromanometer was gradually withdrawn
until its catheter artifact was no longer evident in the IVUS
image.
Experimental protocol. Hemodynamic and echocardio-
graphic studies were performed both before and after produc-
tion of pacing-induced heart failure. Ganglionic blockade with
hexamethonium bromide (45 mg/kg/IV) was used to avoid the
confounding influence of autonomic reflexes, and animals were
paced to achieve constant heart rates before and after heart
failure. The aorta was “preconditioned” to minimize viscoelas-
tic effects (hysteresis, creep and stress relaxation) by four to
five brief aortic occlusions (16).
Hemodynamic and IVUS data were obtained at baseline.
After baseline data were acquired, the aortic balloon was
inflated in graded steps to acquire several (at least five)
steady-state runs representing a range of aortic distending
pressures from baseline to the mean circulatory pressure
(;25 mm Hg). The protocol was repeated after randomly
assigned infusions of both the directly acting vasodilator
sodium nitroprusside (40 to 120 g/min to achieve a 20%
decrease in aortic systolic pressure) and the beta-agonist,
dobutamine, at a fixed dose of 10 mg/kg/min. Thermodilution
cardiac outputs were determined in triplicate and averaged at
baseline and after each pharmacologic intervention.
One animal underwent pacemaker lead implantation with-
out rapid pacing and was used as a sham-operated time
control.
Data acquisition. Intravascular ultrasound studies were
recorded on a Hewlett-Packard Sonos 100 intravascular imag-
ing system. Ultrasound images were recorded continuously on
one half–inch S-VHS videotape.
The micromanometer and fluid-filled catheters were cali-
brated before implantation with a mercury manometer. Zero
drift of the micromanometer was corrected by matching the
aortic pressure measured simultaneously through the fluid-
filled lumen. Fluid-filled catheters were connected to 23-dB
transducers with zero pressure at the level of the mid right
atrium. Analog signals for the high fidelity and fluid-filled
aortic pressures, pulmonary arterial and right atrial pressures
and the electrocardiogram were recorded on-line on a Gould
multichannel recorder and digitized every 2 ms through an
analog-to-digital board (Dual Control Systems) interfaced to a
Comp-U-Dyne 486 DX and stored on floppy disk. Data were
acquired over 5 s with respiration suspended at end inspiration.
The electrocardiogram was recorded simultaneously via the
auxiliary channel of the ultrasonograph. A synchronizing event
marker was registered on both the ultrasonograph and the
Gould recorder.
Data analysis. Cross-sectional video images of the aorta
were analyzed off-line on a dedicated image analysis system
(Tomtec). Images were replayed by using a videocassette
recorder with high quality still/slow capability and viewed on a
high resolution video monitor.
The internal vessel circumferences were measured by trac-
ing the acoustic interface between the lumen and the intimal
leading edge, and the external circumference was measured by
tracing the acoustic interface between the medial–adventitial
border. Preocclusion data were analyzed at both maximum
(end systole) and minimum aortic dimension; steady-state
measurements during occlusion were made at maximum di-
mension only. Measurements were made from three cycles and
were averaged. Internal and external vessel diameter were
calculated from their respective circumferences:
D 5 circumference/p.
Curve fitting and calculation of elastic properties. Aortic
systolic and maximum internal vessel diameters were fit to a
simple monoexponential equation:
P 5 AeKpdD,
where valve P is the aortic systolic pressure, D is the corre-
sponding maximal internal vessel diameter, A is the pressure
intercept, e is the base of the natural logarithm, and Kpd is the
chamber stiffness constant.
Stress was calculated using the law of Laplace:
Stress 5 P 3 D/2h,
where h 5 aortic wall thickness.
Strain was computed as a natural strain:
strain 5 ln ~D/Dmin!,
where Dmin is the diameter at mean circulatory pressure (aortic
balloon completely inflated).
Abbreviations and Acronyms
IVUS 5 intravascular ultrasound
kpd 5 stiffness constant of the pressure–dimension relation
kss 5 stiffness constant of the stress–strain relation
SVR 5 systemic vascular resistance
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Stress–strain data were also fitted to a simple monoexpo-
nential equation:
s 5 Aekss«,
where s 5 stress, « 5 strain and kss is the material stiffness
constant. Pressure–dimension and stress–strain data were
measured from aortic occlusions taken at baseline and during
nitroprusside and dobutamine; measurements were made both
before and after heart failure was produced.
Interpretative variability. Measurement variability for aor-
tic circumferences were assessed by measuring randomly se-
lected intravascular ultrasound images (n 5 20) for two
blinded observers. Differences were calculated as the differ-
ence between two observations divided by the mean of the two
observations, and expressed as a percent.
Statistics. Group data are expressed as mean 6 SD. Two-
way repeated measures analysis of variance was used to test the
effects of pharmacologic agents and heart failure; when a
significant interaction was present, differences were tested with
contrasts. Paired t tests were used to compare parameters in
the control and heart failure groups. Differences were consid-
ered significant at a value of p , 0.05.
Results
The percent interobserver difference for luminal–intimal
and medial–adventitial border measurements (n 5 49 beats)
were 7.0 6 3.4% and 5.8 6 3.2%, respectively.
Comparison of control and heart failure data at baseline.
The systemic arterial pressure was significantly lower and the
systemic vascular resistance was significantly greater in dogs
after production of congestive heart failure than obtained in
the same animal before heart failure (Table 1).
Nitroprusside produced a 20.4% fall in systemic vascular
resistance (SVR) in the control state and a 22.3% decrease in
SVR after heart failure was produced (both p , 0.05). In
contrast, dobutamine produced a change in SVR only in the
dogs with heart failure.
Cardiac output was significantly greater in the control than
heart failure state (3.8 6 1.1 vs. 2.3 6 3.5 liters/min, p , 0.01)
and increased in response to both nitroprusside and dobut-
amine (p , 0.001).
The aortic diameter decreased and wall thickness increased
in heart failure compared to control dogs. As a result, the wall
thickness to diameter ratio was significantly greater in heart
failure than control dogs (Table 2).
Effect of heart failure and pharmacologic agents on aortic
pressure–diameter relationships. Pressure–diameter curves
from a representative animal are shown in Figure 1, and the
mean chamber stiffness constants (kpd) before and after pro-
duction of heart failure are shown in Table 3. The kpd was
significantly greater after heart failure was produced than
before, indicating decreased aortic compliance owing to
pacing-induced heart failure. There was no significant effect of
either nitroprusside or dobutamine on the kpd in the control
state. In contrast, nitroprusside and dobutamine significantly
reduced kpd and shifted the pressure–dimension relation sig-
nificantly to the right with heart failure. However, the pres-
sure–dimension relation did not return to that observed in the
control state.
Effects of heart failure and pharmacologic agents on aortic
stress–strain relationships. Stress–strain curves from a repre-
sentative animal are shown in Figure 2, and mean aortic
material stiffness constants are shown in Table 3. The stiffness
constant of the stress–strain relation, kss, was unaffected by
pacing-induced heart failure. Moreover, the stiffness constant
was not altered by nitroprusside and dobutamine either before
or after production of heart failure.
No changes were observed in the sham-operated time
control dog.
Discussion
The present study examined aortic mechanics over a wide
range of systolic aortic pressures using intravascular ultrasound
and high fidelity pressure measurements and graded balloon
occlusion of the aorta in the normal and heart failure canine
model in vivo. The principal finding of this study is that aortic
compliance is decreased in pacing-induced heart failure, and
the reduced aortic compliance in heart failure returns toward
normal with the use of the vasodilator nitroprusside and the
inotropic agent dobutamine.
Table 2. Changes in Aortic Diameter and Wall Thickness in Pacing-





Control 0.92 6 0.11 0.15 6 0.03 0.16 6 0.03
PHF 0.73 6 0.08* 0.22 6 0.05* 0.30 6 0.08*
*p , 0.05 vs. control.
Table 1. Hemodynamic Changes With Intervention
Baseline Nitroprusside Dobutamine
HR (bpm) BP (mm Hg) SVR (dynzszcm25) HR (bpm) BP (mm Hg) SVR (dynzszcm25) HR (bpm) BP (mm Hg) SVR (dynzszcm25)
CON 121 6 15 143 6 16 2,170 6 331 144 6 10* 117 6 22* 1,727 6 408* 144 6 6* 195 6 52*† 2,110 6 783
PHF 130 6 14 117 6 12‡ 2,929 6 403‡ 146 6 8* 98 6 13 2,275 6 362*‡ 149 6 9* 119 6 16‡ 2,384 6 425*
*p , 0.05 vs. baseline. †p , 0.05 vs. nitroprusside. ‡p , 0.05 vs. control. n 5 7. BP 5 systolic arterial blood pressure; CON 5 control; HR 5 heart rate; PHF 5
pacing-induced heart failure; SVR 5 systemic vascular resistance.
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Aortic compliance in heart failure. The mechanisms re-
sponsible for altered aortic compliance in congestive heart
failure are incompletely understood and include alterations of
the vascular wall (i.e., collagen, elastin, vascular smooth mus-
cle) changes in vessel geometry (remodeling) and neurohor-
monal influences. We showed that congestive heart failure is
associated with increased wall thickness, both in absolute terms
and relative to the luminal diameter. An important finding is
that change in aortic compliance in pacing-induced heart
failure is attributable largely to geometric factors, rather than
to material properties of the vessel, since the stiffness constant
of the stress–strain relation (which accounts for vessel geom-
etry and reflects changes in material properties) was un-
changed after heart failure was produced. Another possible
mechanism for vessel remodeling and the resultant decreased
aortic compliance in heart failure is sodium retention within
the vessel wall. Administration of mineralocorticoids to induce
salt retention has been shown to increase vascular stiffness
(17). Although a potential explanation is that operative com-
pliance is decreased secondary to an overdistended aorta
operating on a steeper portion of its pressure–diameter rela-
tionship, this is unlikely, since aortic diameters were lower in
the animals with heart failure compared to control animals.
The structural basis for changes in aortic compliance is
better characterized for aging and hypertension than for heart
failure. Reduced aortic compliance in hypertension is associ-
ated with increased arterial wall thickness and changes in the
structural composition of the arterial wall (18). There is
evidence that the elevated arterial pressure is not the only
determinant of medial hypertrophy (19). Angiotensin II has
been implicated in the adaptive vascular changes during hy-
pertension; studies have shown that angiotensin II exerts a
hypertrophic effect and induces polyploidy in vascular smooth
muscle cells (4), and that local vascular renin angiotensin
systems exist (20). There is also evidence that long-term
angiotensin-converting enzyme inhibition may normalize arte-
rial stiffness and vascular architecture in hypertensive rats (18).
Figure 1. Representative pressure–dimension curves before (top) and
after (bottom) pacing-induced heart failure in the baseline state
(squares) and after nitroprusside (circles) and dobutamine (triangles).
A shift of the pressure–dimension relation with nitroprusside and
dobutamine occurred only after heart failure was produced.
Table 3. Pressure–Dimension and Stress–Strain Relations: Effects of Pacing-Induced Heart Failure
(PHF) and Pharmacologic Agents
Pressure–Dimension (mm Hg/cm) Stress–Strain (mm Hg)
Baseline Nitroprusside Dobutamine Baseline Nitroprusside Dobutamine
Control 6.7 6 1.5 6.9 6 1.3 6.9 6 1.8 11.3 6 1.0 11.3 6 2.9 11.6 6 1.9
PHF 10.0 6 2.3* 8.3 6 1.9*† 8.3 6 1.8*† 11.4 6 1.8 11.7 6 1.2 12.5 6 1.2
*p , 0.05 vs. control. †p , 0.05 vs. baseline.
Figure 2. Stress–strain curves before (top) and after (bottom) pacing-
induced heart failure in the baseline state (squares) and after nitro-
prusside (circles) and dobutamine (triangles). Stress–strain relations
were similar in both states.
270 KHAN ET AL. JACC Vol. 33, No. 1
AORTIC COMPLIANCE IN HEART FAILURE January 1999:267–72
Effect of drugs on arterial compliance. The resting caliber
of the aorta depends on the balance between passive (pressure-
induced) expansion and active contraction (16). Pressure de-
pendence of arterial caliber is evident in that a fall of blood
pressure from 143 6 16 mm Hg to 21 6 9 mm Hg (all baseline
runs) produced a 39% decrease in diameter. Smooth muscle
relaxation produced by nitroprusside increased aortic compli-
ance significantly in the heart failure dogs, although not quite
to the levels observed in normal control dogs; that is, the aorta
remained stiffer than the aorta in control animals under a
similar degree of vasodilation. Nevertheless, our results are
similar to those of Pepine et al., who showed that nitroprusside
increased aortic compliance in patients with congestive heart
failure (21).
There are four competing factors that determine the effect
of a vasoactive drug on aortic compliance. First is the direct
effect of the drug on the aortic wall smooth muscle. The active
tension that the smooth muscle can generate is estimated
between 1.5 and 2.5 3 105 dyn/cm2 (4); the loss of this tension
as a result of smooth muscle relaxation should increase vessel
compliance. Second, a vasoactive drug may alter aortic diam-
eter. If an artery exhibits the same change in radius for a given
change in pressure in both the vasodilated and vasoconstricted
state, then the former will be more compliant than the latter
because of geometric considerations. Third, the arterial size
resulting from a vasoactive agent may influence the fractional
recruitment of collagen. The relation between pressure and
diameter (or stress and strain) in a blood vessel is curvilinear
and concave toward the pressure or stress axis. This is partly a
result of differential loading of the distensible elastin and
relatively stiff collagen at different pressure (stress) or diame-
ter (strain) (22,23). As smooth muscle is relaxed and arterial
caliber increases, one would expect the fractional recruitment
of collagen to increase and the vessel to become less compliant.
The final factor relates to the interaction or linking between
collagen, elastin and smooth muscle within the arterial wall.
Although a number of models have been proposed for the
arrangement (series and parallel) (24), there is as yet no
general agreement on a model that fits all the experimental
data. Several investigators have proposed that smooth muscle
in the arterial wall functions in series with collagen, and both
operate in parallel with elastin (22). During smooth muscle
contraction the collagen jacket is tensed, making the vessel
stiffer, and with smooth muscle relaxation stress is released
from collagen and transferred to the more distensible elastin.
The data from our study of heart failure animals is in agree-
ment with this model. If the slopes of the pressure–area curves
are examined at equivalent diameters (Fig. 2), it is apparent
that the vasodilated vessel is markedly more compliant than at
baseline.
Dobutamine also decreased aortic stiffness in dogs with
heart failure. This finding is consistent with results from a
previous heart failure study in which therapy with dobutamine
produced beneficial changes in the aortic impedance spectrum,
that is, impedance matching and facilitation of ventricular
vascular coupling (6).
The effects of vasodilation on aortic compliance are not
apparent in dogs without heart failure and contrast with other
studies (25,26). One possible explanation is that the arteries
studied in these cases were all muscular arteries; the effects of
drugs on arterial caliber in muscular arteries is likely to be
greater than those on elastic arteries such as the aorta. This
assumption is consistent with the hypothesis that vascular
smooth muscle hypertrophy in the aorta of heart failure
animals is responsible for the altered compliance and vasore-
activity.
Methodological considerations. A number of potential
limitations merit comment. First, an important issue regarding
the techniques used to assess aortic elastic mechanics is the
precision and reproducibility of aortic circumference and wall
thickness measurements. Intravascular ultrasound measure-
ments have been shown in a number of studies to correlate well
with angiographic and pathologic assessments of arterial lumi-
nal dimensions and wall thickness (27–29). Nevertheless, the
method has potential limitations including artifacts owing to
catheter tilt and blood and wall echo signal attenuation.
Second, the elastic parameters measured with this technique
were obtained from a wide range of pressures generated by
graded balloon occlusion of the aorta. The potential of viscous
and inertial behavior influencing the purely elastic behavior of
the aorta cannot be entirely ruled out. However, prior to each
experiment “preconditioning” of the aorta was done by re-
peated graded inflation and deflation of the balloon. Third, our
method of aortic pressure alteration may itself produce reflex
changes in the determinants of aortic compliance. Reflex
alterations were minimized in our protocol by employing
ganglionic blockade. Moreover, the aortic balloon was inflated
sufficiently proximal to the catheters so as not to directly
interfere with pressure–diameter measurements. Finally, de-
spite the mechanistic insights, careful histologic and molecular
biologic analysis of the arterial wall are necessary to completely
understand the findings in our study.
Clinical implications. The pathophysiologic and therapeu-
tic implications of these findings are considerable. Structural
changes in the conduit arteries are maladaptive in that they
increase left ventricular afterload and reduce left ventricular
pump efficiency. We have shown that vasodilators have differ-
ential effects on resistance and conduit vessels. It is interesting
to speculate that the beneficial effects of angiotensin-
converting enzyme inhibitors in heart failure are due, in part,
to large vessel remodeling with resultant increased compliance.
The framework established in this study may be used for the
development of pharmacologic therapies that specifically affect
aortic compliance and favorably influence ventricular–arterial
coupling and hydraulic efficiency of the left ventricle.
Conclusions. An intravascular technique for measurement
of aortic elastic properties in the normal and heart failure
canine model in vivo has been described. We conclude that 1)
aortic compliance is decreased in the rapid pacing model of
congestive heart failure; 2) this change is attributable primarily
to vessel geometry rather than material properties, and 3)
equivasodilating doses of nitroprusside and equivalent doses of
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dobutamine increase aortic compliance in dogs with congestive
heart failure, but not in the normal dogs.
We acknowledge the expert secretarial assistance of Norma Burns.
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